Table 2.
Patient characteristics at first and second presentation in those who presented on two separate occasions (N = 36)
| Characteristics | Patient characteristics by presentation |
||
|---|---|---|---|
| First presentation (n = 36) | Second presentation (n = 36) | P-value | |
| Patient identification, n | 0.03 | ||
| Symptoms only | 85 | 93 | |
| Symptoms and contact | 15 | 4 | |
| No symptoms but contact | 0 | 0 | |
| Routine screening | 0 | 4 | |
| Presenting symptoms, % | |||
| Sore throat | 17 | 1 | 0.41 |
| Cough | 56 | 64 | 0.18 |
| Shortness of breath | 22 | 53 | 0.002 |
| Fever | 50 | 64 | 0.13 |
| Headache | 14 | 19 | 0.16 |
| Nausea or vomiting | 6 | 19 | 0.03 |
| Diarrhoea | 14 | 25 | 0.16 |
| Myalgia or arthralgia | 26 | 25 | 0.71 |
| Vital signs, mean ± SD | |||
| Temperature (°C) | 37.3 ± 1.2 | 37.6 ± 0.9 | 0.19 |
| Respiration rate (per min) | 17 ± 4 | 23 ± 9 | 0.003 |
| O2 saturation room air (%) | 97 ± 3 | 90 ± 10 | 0.001 |
| SBP (mm Hg) | 129 ± 22 | 133 ± 26 | 0.44 |
| DBP (mm Hg) | 69 ± 15 | 70 ± 14 | 0.67 |
| Pulse rate (bpm) | 73 ± 11 | 78 ± 13 | 0.04 |
| Laboratory test results | |||
| Creatinine increase (>25%)a | 25 | 62 | 0.001 |
| Lymphocytes (×1000/µL), median (IQR) | 0.7 (0.5–1.1) | 0.7 (0.4–0.9) | 0.02 |
| CRP (mg/L), median (IQR) | 26 (6–58) | 73 (21–151) | <0.001 |
Groups were compared using Student’s t, Wilcoxon or chi-square test as appropriate. O2, oxygen; SBP, systolic blood pressure; DBP, diastolic blood pressure; bpm, beats per minute. aIn transplant recipients only.